ENPICOM

ENPICOM is a bioinformatics software company that provides a unified platform for accelerating the discovery and development of new biologics. The platform is designed to serve lab scientists, data scientists, and machine learning (ML) scientists alike, integrating best-in-class bioinformatics tools, a scalable data foundation, and advanced ML frameworks into a single cohesive solution. Founded with deep expertise in immunology, antibody discovery, machine learning, software engineering, synthetic biology, genetics, and molecular biology, ENPICOM empowers research organizations to simplify scientific workflows and fast-forward biologics R&D.

Trusted by global leaders in innovative research, ENPICOM operates with 84% of its workforce devoted to R&D, achieves an average user satisfaction NPS score of 87%, and delivers unmatched processing speeds of over 1.55 million reads per minute. The company's interdisciplinary team brings together specialists across immunology, bioinformatics, machine learning, and software engineering to deliver future-ready, flexible solutions.

The ENPICOM Platform: Core Architecture

• Data Foundation: A high-performance, scalable data architecture that makes large sequencing datasets and historical data instantly accessible. The platform integrates seamlessly into existing ecosystems or federated data warehouses, eliminating data silos. Its proprietary architecture enables complex queries on hundreds of millions of sequences in seconds.
• Workflow Automation: Standardized, automated bioinformatics pipelines that reduce complexity, enhance collaboration, and ensure high-quality data availability for AI model training. Workflows can be rapidly adapted to specific lab protocols, project needs, or research goals, ensuring data harmonization across teams.
• AI Integration: End-to-end management of the ML model lifecycle, including model training, version tracking, and seamless deployment. Scientists can release AI models directly into real-world discovery campaigns, transforming months of AI development into actionable insights accessible with a single click — without requiring dedicated data science support.

Key Capabilities for Biologics Research

• Direct access to AI models within research workflows, enabling lab scientists to leverage machine learning without dependency on data scientists
• Fast, flexible, and accurate sequence annotation
• State-of-the-art developability assessment tools for evaluating biologics candidates
• Support for hit selection, diversity picking, hit expansion, and enrichment analysis
• No-code solution for running advanced analysis workflows using readily available or in-house developed algorithms
• Comprehensive API enabling full integration with existing research ecosystems and the ability to query billions of historical clones in seconds
• Support for custom algorithm integration and tailored workflow configuration

Software Modules and Services

• Platform Overview: A unified interface bringing together data management, storage, ML training, and discovery analysis
• Data Foundation Module: Scalable infrastructure for managing and querying large-scale sequencing and historical datasets
• Automation Module: Streamlined pipeline management for consistent, reproducible bioinformatics workflows
• Discovery Tooling: Analytical tools supporting biologics research from hit identification through candidate optimization
• AI Integration Module: Tools for model deployment, lifecycle management, and integration into automated or visualization-driven workflows
• Analysis Services: Expert-led bioinformatics analysis services provided by the ENPICOM team
• Antibody Humanization Services: Specialized services supporting the humanization of antibody candidates

Use Cases Supported

• Model Deployment: Seamless integration of AI models into biologics discovery and engineering campaigns
• Developability Assessment: Evaluating the drug-like properties of biologics candidates early in the discovery process
• Hit Selection: Identifying promising candidates from large screening datasets
• Hit Expansion: Exploring sequence space around confirmed hits to identify related candidates
• Enrichment Analysis: Analyzing sequencing data to identify enriched populations of interest
• Vaccine Research: Simplifying analysis and decision-making workflows for vaccine-related biologics programs

Why Organizations Choose ENPICOM

• Discover Better Biologics: Enables seamless AI integration so lab scientists can use machine learning models effectively without relying on data science teams, accelerating lead selection and candidate optimization
• Streamlined MLOps: Eliminates redundant tasks and unifies the entire ML lifecycle — from experimentation to production — covering model training, tracking, and deployment in a single system
• Maximized ROI: Increases return on AI investments by fostering collaboration between ML and lab scientists, speeding up model development, driving broader ML adoption, and reducing maintenance costs
• Three-Step AI Adoption Blueprint: A structured methodology — building a strong data foundation, automating bioinformatics pipelines, and integrating AI — designed to de-risk development and accelerate lead selection
• Ecosystem Integration: A comprehensive API and adaptable infrastructure ensure the platform fits into any existing research ecosystem, with a dedicated team providing tailored solutions that evolve with research demands

ENPICOM is backed by BOP Impact Ventures and angel investor Colby Souders, PhD, and continues to grow its interdisciplinary team with expertise spanning machine learning, bioinformatics, software engineering, and molecular biology. The company offers personalized demos and consultations for organizations looking to power their ML journey through seamless collaboration between data and lab scientists.